Your session is about to expire
← Back to Search
Microbiota Transfer Therapy for Autism and Gastrointestinal Issues
Study Summary
This trial will study whether Microbiota Transfer Therapy is an effective treatment for children with Autism Spectrum Disorder and gastrointestinal problems.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Group A - Treatment Group
- Group 2: Group B - Control Group (Miralax only for 1 day)
Frequently Asked Questions
In what manner are vancomycin, Miralax, and intestinal microbiota commonly deployed?
"Vancomycin, Miralax and intestinal microbiota are routinely used to treat colonoscopy. Additionally, they can help patients who suffer from clostridium difficile associated diarrhea (CDAD), staphylococcal infections, or need bowel preparation therapy."
Could you provide a synopsis of previous experiments conducted concerning vancomycin, Miralax, and intestinal microbiota?
"Presently, there are 69 active trials for vancomycin, Miralax and intestinal microbiota with 6 of those studies in Phase 3. Location wise, Cleveland Ohio is a major hub but the research spans over 338 sites globally."
Is this research open to geriatric participants?
"As per the conditions of this study, the minimum age for enrolment is 5 years old and the maximum permitted age is 17."
How many participants are being sought for this research project?
"Affirmative. According to clinicaltrials.gov, the trial - first posted on November 15th 2019 - is now actively searching for participants. 70 individuals are required from one medical facility."
Are there any potential risks associated with the ingestion of vancomycin, Miralax and intestinal microbiota?
"The safety of vancomycin, Miralax, and intestinal microbiota was assessed at a level of 2. This is because this Phase 2 trial has collected evidence supporting its safety yet no proof of efficacy."
Are there any open spaces in this clinical trial?
"The data hosted on clinicaltrials.gov verifies that this medical trial is seeking volunteers; the study was first posted in November 15th 2019 and recently revised December 29th 2021."
Am I eligible to participate in the current research program?
"This research is recruiting 70 minors aged between 5-17 with gastrointestinal issues. To be eligible, candidates must not have changed any medication, supplement, diet or therapy in the past 3 months and should not intend to do so throughout the trial. Additionally, they need to be able to swallow pills without chewing them and present a general good health aside from their GI symptoms."
Share this study with friends
Copy Link
Messenger